🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 67092M208
Business: Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy.
Company Contact
- CEO
- R: Gareth Sheridan
- CFO
- Gerald Goodman
- Headquarters
- 121 S. Orange Ave. Suite 1500, Orlando, FL 32801
- Phone
- 407-377-6695
- Investor Relations
- investor.relations@nutriband.com